Bryan Chin

Bryan Chin is an Associate Director of Clinical Operations with extensive experience in managing clinical trials, particularly in the fields of oncology and rare diseases. With six years of clinical trial experience, they currently oversee a phase I/II investigational gene therapy study and a follow-up study for Gaucher disease type I. Bryan previously contributed to the selection and evaluation of clinical CROs for AVROBIO’s follow-up study and has worked in various roles at organizations such as Rubius Therapeutics and BlueRock Therapeutics. They hold a Bachelor of Science degree in Health Sciences from the University of Massachusetts Boston.